Arlington Partners’s CDK Global, Inc. CDK Stock Holding History

Arlington Partners’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9	Closed	–	–	414
2021 Q2	$0	Hold	9	–	–	﹤0.01%	390
2021 Q1	$0	Buy	+9	New	+$467	﹤0.01%	419

Other funds holding CDK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Arlington Partners's CDK Position: Q3 2021 in Review

Arlington Partners sold out of CDK Global, Inc. (CDK) in Q3 2021, closing a stake of 9 shares.

Arlington Partners first reported a position in CDK in Q1 2021 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 422 funds tracked by Wall St. Rank hold CDK as of Q3 2021.

Arlington Partners reported no remaining CDK Global, Inc. position as of Q3 2021 after selling out during the quarter.
Arlington Partners sold 9 CDK Global, Inc. shares in Q3 2021.
Arlington Partners first reported a position in CDK Global, Inc. in Q1 2021 and held it in 2 quarters.
Arlington Partners's CDK Global, Inc. position peaked at $0 in Q2 2021.
422 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2021.

Based on Arlington Partners's 13F filing for Q3 2021, filed 15 Oct 2021.